Skip to main content
Top
Published in: Clinical and Experimental Nephrology 7/2021

Open Access 01-07-2021 | Microalbuminuria | Original article

Prediction of microalbuminuria from proteinuria in chronic kidney disease due to non-diabetic lifestyle-related diseases: comparison with diabetes

Authors: Makoto Ogi, Takuya Seto, Yoshinori Wakabayashi

Published in: Clinical and Experimental Nephrology | Issue 7/2021

Login to get access

Abstract

Background

To suppress increases in kidney failure and cardiovascular disease due to lifestyle-related diseases other than diabetes, early intervention is desirable. We examined whether microalbuminuria could be predicted from proteinuria.

Methods

The participants consisted of adults who exhibited a urinary protein-to-creatinine ratio (uPCR) of < 0.5 g/gCr and an eGFR of ≥ 15 ml/min/1.73 m2 in their spot urine at their first examination for lifestyle-related disease. Urine was tested three times for each case, with microalbuminuria defined as a urinary albumin-to-creatinine ratio (uACR) of 30–299 mg/gCr, at least twice on three measurements. Youden’s Index was used as an index of the cut-off value (CO) according to the ROC curve.

Results

A single uPCR was useful for differentiating normoalbuminuria and micro- and macroalbuminuria in patients with non-diabetic lifestyle-related diseases. Regarding the GFR categories, the CO of the second uPCR was 0.09 g/gCr (AUC 0.89, sensitivity 0.76, specificity 0.89) in G1-4 (n = 197) and 0.07 g/gCr (AUC 0.92, sensitivity 0.85, specificity 0.88) in G1-3a (n = 125). Using the sum of two or three uPCR measurements was more useful than a single uPCR for differentiating microalbuminuria in non-diabetic lifestyle disease [CO, 0.16 g/gCr (AUC 0.91, sensitivity 0.85, specificity 0.87) and 0.23 g/gCr (AUC 0.92, sensitivity 0.88, specificity 0.84), respectively].

Conclusion

Microalbuminuria in Japanese individuals with non-diabetic lifestyle-related diseases can be predicted from the uPCR, wherein the CO of the uPCR that differentiates normoalbuminuria and micro- and macroalbuminuria was 0.07 g/gCr for G1-3a, while that in G3b-4 was 0.09 g/gCr.
Literature
1.
go back to reference Kidney Disease: Improving Global Outcomes. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):19–90. Kidney Disease: Improving Global Outcomes. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):19–90.
2.
go back to reference Japanease Society of Nephrology. Evidence-based Clinical Practice Guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef Japanease Society of Nephrology. Evidence-based Clinical Practice Guideline for CKD 2013. Clin Exp Nephrol. 2014;18:346–423.CrossRef
3.
go back to reference Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, Japanese Society for Dialysis Therapy Renal Data Registry Committee. Annual dialysis data report 2017, JSDT Renal data registry. Renal Replace Ther. 2019. https://doi.org/10.1186/s41100-019-0248-1.CrossRef Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, Japanese Society for Dialysis Therapy Renal Data Registry Committee. Annual dialysis data report 2017, JSDT Renal data registry. Renal Replace Ther. 2019. https://​doi.​org/​10.​1186/​s41100-019-0248-1.CrossRef
4.
go back to reference Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, The research group of diabetic nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20.CrossRef Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, The research group of diabetic nephropathy, Ministry of Health, Labour, and Welfare of Japan. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2014;18:613–20.CrossRef
5.
go back to reference Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetics and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRef Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetics and nondiabetic individuals. JAMA. 2001;286:421–6.CrossRef
6.
go back to reference Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;2004(110):32–5.CrossRef Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;2004(110):32–5.CrossRef
7.
go back to reference Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol. 2007;2:581–90.CrossRef Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol. 2007;2:581–90.CrossRef
8.
go back to reference Segura J, Campo C, Ruilope LM. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int Suppl. 2004;92:S45–9.CrossRef Segura J, Campo C, Ruilope LM. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int Suppl. 2004;92:S45–9.CrossRef
9.
go back to reference van der Velde M, Bello AK, Brantama AH, EI Nahas M, Bakker SJ, de Jong PE, et al. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant. 2012;27:2275–83.CrossRef van der Velde M, Bello AK, Brantama AH, EI Nahas M, Bakker SJ, de Jong PE, et al. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant. 2012;27:2275–83.CrossRef
10.
go back to reference Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D’Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–75.CrossRef Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D’Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112:969–75.CrossRef
12.
go back to reference Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–74.CrossRef Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–74.CrossRef
13.
go back to reference Sato H, Konta T, Ichikawa K, Suzuki N, Kabasawa A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata(Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef Sato H, Konta T, Ichikawa K, Suzuki N, Kabasawa A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata(Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef
14.
go back to reference Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRef Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRef
15.
go back to reference Collier G, Greenan MC, Brady JJ, Murray B, Cunningham SK. A study of the relationship between albuminuria, proteinuria and urinary reagent strips. Ann Clin Biochem. 2009;46:247–9.CrossRef Collier G, Greenan MC, Brady JJ, Murray B, Cunningham SK. A study of the relationship between albuminuria, proteinuria and urinary reagent strips. Ann Clin Biochem. 2009;46:247–9.CrossRef
16.
go back to reference Methven S, MacGregor MS, Traynor JP, O’Reilly DS, Deighan CJ. Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratio. Nephrol Dial Transplant. 2010;25:2991–6.CrossRef Methven S, MacGregor MS, Traynor JP, O’Reilly DS, Deighan CJ. Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratio. Nephrol Dial Transplant. 2010;25:2991–6.CrossRef
17.
go back to reference Wu MT, Lam KK, Lee WC, Hsu KT, Wu CH, Cheng BC, Ng HY, Chi PJ, Lee YT, Lee CT. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012;26:82–92.CrossRef Wu MT, Lam KK, Lee WC, Hsu KT, Wu CH, Cheng BC, Ng HY, Chi PJ, Lee YT, Lee CT. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012;26:82–92.CrossRef
18.
go back to reference Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complication of CKD: a cross-sectional analysis. Am J Kidney Dis. 2013;62:1102–8.CrossRef Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complication of CKD: a cross-sectional analysis. Am J Kidney Dis. 2013;62:1102–8.CrossRef
19.
go back to reference Weaver RG, James MT, Ravani P, Weaver CGW, Lamb EJ, Tonelli M, Manns BJ, Quinn RR, Jun M, Hemmelgarn BR. Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: development of equations using same-day measurements. J Am Soc Nephrol. 2020;31:591–601.CrossRef Weaver RG, James MT, Ravani P, Weaver CGW, Lamb EJ, Tonelli M, Manns BJ, Quinn RR, Jun M, Hemmelgarn BR. Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: development of equations using same-day measurements. J Am Soc Nephrol. 2020;31:591–601.CrossRef
20.
go back to reference Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, Furth SL, Warady BA, Moxey-Mims MM, Schwartz GJ. Alubuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol. 2017;12:912–20.CrossRef Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, Furth SL, Warady BA, Moxey-Mims MM, Schwartz GJ. Alubuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol. 2017;12:912–20.CrossRef
21.
go back to reference Harrel FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Berlin: Springer International Publishing; 2020. Harrel FE. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Berlin: Springer International Publishing; 2020.
22.
go back to reference Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured. Ann Clin Biochem. 2009;46:215–7.CrossRef Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured. Ann Clin Biochem. 2009;46:215–7.CrossRef
23.
go back to reference ChristenEI NR, Birn H. Renal filtration, transport, and metabolism of albumin and albuminuria. In: Alpen RJ, Caplan MJ, Moe O, editors. Seldin and Giebischs the kidney physiology and pathophysiology. Amsterdam: Elsevier; 2013. p. 2457–74. ChristenEI NR, Birn H. Renal filtration, transport, and metabolism of albumin and albuminuria. In: Alpen RJ, Caplan MJ, Moe O, editors. Seldin and Giebischs the kidney physiology and pathophysiology. Amsterdam: Elsevier; 2013. p. 2457–74.
Metadata
Title
Prediction of microalbuminuria from proteinuria in chronic kidney disease due to non-diabetic lifestyle-related diseases: comparison with diabetes
Authors
Makoto Ogi
Takuya Seto
Yoshinori Wakabayashi
Publication date
01-07-2021
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 7/2021
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-021-02027-6

Other articles of this Issue 7/2021

Clinical and Experimental Nephrology 7/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.